NDC 71335-2575 – Desvenlafaxine

Desvenlafaxine Succinate 50 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC71335-2575

Product details

Brand name
Desvenlafaxine
Generic name
Desvenlafaxine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204028
Marketed since
January 31, 2022
Listing expires
December 31, 2026
Pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Desvenlafaxine →

Package NDC codes (5)

Package NDCDescriptionSince
71335-2575-130 TABLET, EXTENDED RELEASE in 1 PACKAGE (71335-2575-1)Feb 5, 2025
71335-2575-228 TABLET, EXTENDED RELEASE in 1 PACKAGE (71335-2575-2)Feb 5, 2025
71335-2575-360 TABLET, EXTENDED RELEASE in 1 PACKAGE (71335-2575-3)Feb 5, 2025
71335-2575-490 TABLET, EXTENDED RELEASE in 1 PACKAGE (71335-2575-4)Feb 5, 2025
71335-2575-5180 TABLET, EXTENDED RELEASE in 1 PACKAGE (71335-2575-5)Feb 5, 2025

Other Desvenlafaxine products